首页> 外文期刊>Journal of Crohn’s & colitis >Microscopic colitis: Current status, present and future challenges: Statements of the European Microscopic Colitis Group
【24h】

Microscopic colitis: Current status, present and future challenges: Statements of the European Microscopic Colitis Group

机译:显微结肠炎:现状,当前和未来挑战:欧洲显微结肠炎集团的声明

获取原文
获取原文并翻译 | 示例
           

摘要

Microscopic colitis (MC) is an inflammatory bowel disease presenting with chronic, non-bloody watery diarrhoea and few or no endoscopic abnormalities. The histological examination reveals mainly two subtypes of MC, lymphocytic or collagenous colitis. Despite the fact that the incidence in MC has been rising over the last decades, research has been sparse and our knowledge about MC remains limited. Specialists in the field have initiated the European Microscopic Colitis Group (EMCG) with the primary goal to create awareness on MC. The EMCG is furthermore a forum with the intention to promote clinical and basic research. In this article statements and comments are given that all members of the EMCG have considered being of importance for a better understanding of MC. The paper focuses on the newest updates in epidemiology, symptoms and diagnostic criteria, pathophysiology and highlights some unsolved problems. Moreover, a new treatment algorithm is proposed on the basis of new evidence from well-designed, randomized control trials.
机译:显微镜结肠炎(MC)是一种炎症性肠病,表现为慢性非血性水样腹泻,很少或没有内镜异常。组织学检查主要显示MC的两种亚型,淋巴细胞性或胶原性结肠炎。尽管过去几十年来MC的发病率一直在上升,但研究却很少,我们对MC的了解仍然有限。该领域的专家发起了欧洲显微结肠炎小组(EMCG),其主要目标是提高人们对MC的认识。 EMCG还是一个旨在促进临床和基础研究的论坛。本文中的陈述和评论表明,EMCG的所有成员都认为对更好地理解MC非常重要。本文重点关注流行病学,症状和诊断标准,病理生理学的最新进展,并重点介绍一些尚未解决的问题。此外,基于精心设计的随机对照试验的新证据,提出了一种新的治疗算法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号